Epigenetic attenuation of interferon signaling is associated with aging-related improvements in systemic lupus erythematosus
Authors:
- Rithwik NarendraRNRithwik Narendra
- Hoang Van PhanHPHoang Van Phan
- Sarah L. PattersonSarah L. Patterson
- Ana Almonte-LoyaAAAna Almonte-Loya
- Emily C. LydonEmily C. Lydon
- Cristina LanataCristina Lanata
- Joonsuk ParkJPJoonsuk Park
- Michiko ShimodaMichiko Shimoda
- Lisa BarcellosLisa Barcellos
- Honey MekonenHMHoney Mekonen
- Angela DetweilerAngela Detweiler
- 25 June 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (804) , eadt5550
Abstract
In the general population, aging is associated with an increase in systemic inflammation and chronic disease burden. However, in systemic lupus erythematosus (SLE), older age is uniquely associated with a decrease in disease activity, suggesting a distinct relationship between aging and inflammation. Using a multiomic approach, we compared aging-related changes in the peripheral blood immune profiles of 287 patients with SLE and 928 healthy controls. In patients with SLE, aging correlated with lower expression of interferon (IFN)–stimulated genes (ISGs) across multiple cell types, decreased plasma IFN-α2, and differential genome methylation. Both patients with SLE and controls demonstrated age-related declines in naïve T cells, but only patients with SLE exhibited increases in CD56 dim natural killer cells with older age. Of the genes both down-regulated and hypermethylated with older age, ISGs were disproportionately represented, suggesting a role for epigenetic silencing. Altogether, we found that patients with SLE exhibit unique aging-related decreases in IFN signaling that correlate with improved disease activity.Keywords
This publication has 59 references indexed in Scilit:
- Interferon‐α regulates abnormally increased expression of RSAD2 in Th17 and Tfh cells in systemic lupus erythematosus patientsEuropean Journal of Immunology, 2023
- Objectives, design and main findings until 2020 from the Rotterdam StudyEuropean Journal of Epidemiology, 2020
- Role of interferons in SLEBest Practice & Research Clinical Rheumatology, 2017
- Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosusArthritis & Rheumatism, 2009
- Systemic lupus erythematosus in the elderlyAutoimmunity Reviews, 2008
- Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosusArthritis & Rheumatism, 2004
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosusArthritis & Rheumatism, 1996
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Serum interferon levels in patients with systemic lupus erythematosusArthritis & Rheumatism, 1982